Present Evidence of Determinants to Predict the Efficacy of Renal Denervation
Sympathetic overactivation is one of the main contributors to development and progress of hypertension. Renal denervation (RDN) has been evidenced by series of clinical trials for its efficacy and safety to treat overactivated sympathetic nervous system induced diseases. However, the results were in...
Saved in:
Main Authors: | Hao Zhou, Yanping Xu, Weijie Chen, Liang Wang, Huaan Du, Hang Liu, Zhiyu Ling, Yuehui Yin |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | International Journal of Hypertension |
Online Access: | http://dx.doi.org/10.1155/2022/5694127 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Renal Denervation on Ouabain-Induced Hypertension in Rats
by: Minna Tang, et al.
Published: (2024-01-01) -
Renal Denervation for Treating Resistant Hypertension: Current Evidence and Future Insights from a Global Perspective
by: Y. Castro Torres, et al.
Published: (2013-01-01) -
Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension
by: Vasilios Papademetriou, et al.
Published: (2011-01-01) -
Sex-specific differences in the efficacy of renal denervation in patients with resistant hypertension depending on visceral obesity and kidney function
by: Irina Zyubanova, et al.
Published: (2025-01-01) -
Effects of Renal Denervation via Renal Artery Adventitial Cryoablation on Atrial Fibrillation and Cardiac Neural Remodeling
by: Wei Wang, et al.
Published: (2018-01-01)